Colgate-Palmolive shares fell over 3% following its Investor Day, as the company flagged a premiumisation-led growth strategy that may face near-term headwinds. Brokerages including Goldman Sachs have weighed in, with mixed views on the stock's valuation and growth prospects. The market's reaction suggests disappointment over the lack of immediate catalysts or margin expansion clarity.
No articles in the last 24 hours. Expand to 1 week
